In last trading session, Q32 Bio Inc (NASDAQ:QTTB) saw 0.52 million shares changing hands with its beta currently measuring -0.02. Company’s recent per share price level of $1.64 trading at $0.04 or 2.50% at ring of the bell on the day assigns it a market valuation of $20.01M. That closing price of QTTB’s stock is at a discount of -3179.88% from its 52-week high price of $53.79 and is indicating a premium of 14.63% from its 52-week low price of $1.40. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.2 million shares which gives us an average trading volume of 213.71K if we extend that period to 3-months.
For Q32 Bio Inc (QTTB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.33. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.
Q32 Bio Inc (NASDAQ:QTTB) trade information
Upright in the green during last session for gaining 2.50%, in the last five days QTTB remained trading in the red while hitting it’s week-highest on Thursday, 04/03/25 when the stock touched $1.64 price level, adding 8.89% to its value on the day. Q32 Bio Inc’s shares saw a change of -52.33% in year-to-date performance and have moved -4.09% in past 5-day. Q32 Bio Inc (NASDAQ:QTTB) showed a performance of -29.61% in past 30-days. Number of shares sold short was 1.01 million shares which calculate 4.37 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 72 to the stock, which implies a rise of 97.72% to its current value. Analysts have been projecting 64 as a low price target for the stock while placing it at a high target of 80. It follows that stock’s current price would drop -3802.44% in reaching the projected high whereas dropping to the targeted low would mean a loss of -3802.44% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 31.75% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 36.17% while estimates for its earnings growth in next 5 years are of 6.39%.
Q32 Bio Inc (NASDAQ:QTTB)’s Major holders
Insiders are in possession of 8.70% of company’s total shares while institution are holding 86.35 percent of that, with stock having share float percentage of 94.57%. Investors also watch the number of corporate investors in a company very closely, which is 86.35% institutions for Q32 Bio Inc that are currently holding shares of the company. ORBIMED ADVISORS LLC is the top institutional holder at QTTB for having 2.25 million shares of worth $40.44 million. And as of 2024-06-30, it was holding 18.831 of the company’s outstanding shares.
The second largest institutional holder is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, which was holding about 2.09 million shares on 2024-06-30. The number of shares represents firm’s hold over 17.4863 of outstanding shares, having a total worth of $37.55 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 190.8 shares of worth $0.31 million or 1.56% of the total outstanding shares. The later fund manager was in possession of 164.31 shares on Feb 28, 2025 , making its stake of worth around $0.27 million in the company or a holder of 1.35% of company’s stock.
